IndraLab

Statements

MIR135B inhibits CYLD. 2 / 2
| 2
eidos
"Upregulated miR-135b targets the 3'UTR of CYLD , inhibits the expression of CYLD , and subsequently activates NF-kappaB and its downstream factors , which ultimately results in enhanced cell proliferation , migration , invasion , anti-apoptosis , and angiogenesis and confers aggressiveness of NSCLC ( Fig. 8G ) ."
33990540
eidos
"MiR-135b targeted the 3'UTR of CYLD and inhibited CYLD expression , which further potentiated the activation of NF-kappaB signaling ."
33990540